
Artificial Sweetener Sucralose May Reduce Cancer Treatment Effectiveness
New research indicates that sucralose, a common artificial sweetener found in products like Splenda, may impair the effectiveness of cancer immunotherapy by disrupting gut bacteria and reducing arginine levels, but supplementation with arginine could potentially counteract these effects. The study emphasizes the importance of considering dietary factors in cancer treatment outcomes.












